electroCore, Inc. (ECOR) Presents at IAccess Alpha Virtual Best Ideas Summer Investment Conference 2026 Transcript
electroCore to Participate in iAccess Alpha Virtual Best Ideas Summer Investment Conference
Frontiers in Neuroscience Accepts Review Article Synthesizing Evidence that Cervical nVNS Activates the Vagus Nerve Without Surgery
electroCore to Present at the Planet MicroCap Las Vegas 2026 Powered by MicroCapClub
electroCore Touts 30% Growth Outlook, VA Opportunity at LD Micro Conference
electroCore Announces Publication in JAMA Highlighting the Benefits of Adding Quell Electrical Nerve Stimulation to Outpatient Physical Therapy in Fibromyalgia
electroCore Announces Publication Of New Clinical Findings For Quell Device, A Wearable Stimulation Device For The Treatment Of Fibromyalgia
electroCore to Present at the LD Micro Invitational XVI Conference on May 18, 2026
electroCore (ECOR) Q1 2026 Earnings Transcript
electroCore, Inc. Q1 2026 Earnings Call Summary
electroCore, Inc. (ECOR) Q1 2026 Earnings Call Transcript
electroCore Q1 Earnings Call Highlights
electroCore Announces First Quarter 2026 Financial Results
electroCore Affirms FY2026 Sales Guidance of $41.642M vs $41.957M Est
electroCore Q1 EPS $(0.59) Misses $(0.51) Estimate, Sales $9.584M Beat $9.012M Estimate
electroCore TAC-STIM™ Named National Semifinalist in National Safety Council Work to Zero Challenge
electroCore to Announce First Quarter March 31, 2026, Financial Results on Wednesday, May 6, 2026
electroCore to Present at the Market Movers Investor Summit on May 5, 2026
electroCore Product Line Featured in Documentary Underscoring the Expanding Clinical and Commercial Role of Vagus Nerve Stimulation
How The Ecora Royalties (LSE:ECOR) Narrative Is Shifting As Analyst Views Diverge
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.